Matt Plaud – Chief Operations Officer of the IntegriCell platform for Cryoport Systems, LLC. In this
role, he is building a global network of cryopreservation facilities designed to enable the scaling of
cellular therapies. Before joining Cryoport, Matthew held a series of progressively responsible roles
within the SOTIO and the American Red Cross (ARC). He was the President and Chief Operating
Officer for SOTIO Inc., a CAR T cell therapy developer, where he designed and operated a global
cellular therapy supply chain network. In the ARC, he started as a laboratory technician and spent
over 17 years working in different areas of the organization until ultimately completing as the
interim CEO of the Massachusetts Region.
role, he is building a global network of cryopreservation facilities designed to enable the scaling of
cellular therapies. Before joining Cryoport, Matthew held a series of progressively responsible roles
within the SOTIO and the American Red Cross (ARC). He was the President and Chief Operating
Officer for SOTIO Inc., a CAR T cell therapy developer, where he designed and operated a global
cellular therapy supply chain network. In the ARC, he started as a laboratory technician and spent
over 17 years working in different areas of the organization until ultimately completing as the
interim CEO of the Massachusetts Region.